Catalyst Wire Dossier Catalyst Wire Dossier

BIMZELX

BIMEKIZUMAB · UCB, Inc.
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for BIMZELX, covering 2023-10-17 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab) [Phase 1]

See pricing